ARAY Accuray Inc Yalpi foyda normasi

Accuray Inc (ARAY) korporativ emblemasi va logotipi

Accuray Incorporated (ARAY) savdolari hukumat budjetining defitsiti va narxlardagi bosim tufayli cheklanmoqda. Yaqinda foyda marjalari tayanch darajasini ko'rsatmoqda, bunda 28.00 qiymati joriy darajani tavsiflaydi. Barqarorlik CyberKnife tizimining servis to'lovlari bilan birga uzoq operatsion sikli orqali ta'minlanmoqda, biznes modelining moslashuvchanligi esa komponentlarni yig'ish va xalqaro tizim logistikasi uchun tashqi pudratchilarni jalb qilish orqali saqlanib qolmoqda.

Accuray Inc. (ARAY) Yalpi foyda bo'yicha rentabellik: 04.07.2022 - 19.11.2026 davri uchun

accuray.com (ARAY) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning asosiy tahlili:Accuray
Accuray Incorporated tomonidan chiqariladigan mahsulotlar

Accuray Incorporated (ARAY) kompaniyasida aniqlik komponentlari uchun ta'minot zanjiri boshqaruvining samaradorligi bevosita ishlab chiqarish xarajatlarini qoplashdan keyin qoladigan tushum ulushini belgilaydi. Ushbu yalpi foyda grafigi onkologik tizimlar sotuvidan olingan fundamental daromadlarni baholash imkonini beradi va mahsulotlarning eskirish xavflarini o'z vaqtida aniqlashni ta'minlab, aktivlar sifati va biznes modelining raqobatlashish qobiliyatining asosiy ko'rsatkichi bo'lib xizmat qiladi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik